R&D Site in Shanghai

Our headquarters is based in Zhangjiang, Pudong, Shanghai. The Shanghai site has a state-of-the-art laboratory facility that hosts both our discovery unit and the CMC research unit (cell line and analytical development). There are also large open-office spaces hosting the R&D organization, the CMC department and the operation teams. Site address: Suites 802, 505, 702, West Tower, 88 Shangke Road, Pudong New District, Shanghai, China.

Beijing Site

Our Beijing site is located in Changchunjie, Xicheng, Beijing in the vicinity of the NMPA (National Medical Product Administration) and is home to I-Mab’s regulatory affairs team headed by Tiffany Liang. Site address: Room 15A02, Dacheng Mansion, No.127, Xuanwumen West Avenue, XiCheng District, China.

US Site

Our US site is located at 2275 Research Boulevard in Rockville, Maryland. Home to the US FDA, Rockville has a unique blend of biotech and academia with the nearby National Institutes of Health, the National Cancer Institute and Johns Hopkins University. Our US site is dedicated to the clinical development of I-Mab’s global portfolios. Two clinical development strategies have been put in place: one is to work with Center of Excellence Phase I units to expedite clinical development, and the other is to co-develop with other biotech/pharma companies in the US. In conjunction with global BD, we will continue to seek collaboration and partnering opportunities. Our US site is an integral part of our R&D and is critical for our global development strategy.

Copyright I-MAB Biopharma Co., Ltd. all rights reserved 2019 沪ICP备17007960号-1